• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Select Medical Holdings Corporation Completes Spin-Off of Concentra

    11/25/24 5:30:00 PM ET
    $CON
    $SEM
    Medical Specialities
    Health Care
    Hospital/Nursing Management
    Health Care
    Get the next $CON alert in real time by email

    MECHANICSBURG, Pa., Nov. 25, 2024 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical," "we," "us," or "our") (NYSE:SEM) today announced that we have completed our previously announced distribution (the "Distribution") of 104,093,503 shares of common stock of Concentra Group Holdings Parent, Inc. ("Concentra") (NYSE:CON) owned by Select Medical Corporation ("SMC"), a wholly owned subsidiary of Select Medical, representing approximately 81.7% of the outstanding shares of Concentra's common stock. After the completion of the Distribution, Select Medical no longer owns any shares of Concentra's common stock.

    The Distribution was made today to Select Medical's stockholders as of the close of business on the record date (the "Record Date") for the Distribution, November 18, 2024. The Distribution took place in the form of a pro rata common stock distribution to each of Select Medical's stockholder on the Record Date. Based on the shares of Select Medical's common stock outstanding as of the Record Date, Select Medical's stockholders received 0.806971 shares of Concentra's common stock for every share of Select Medical's common stock held as of the Record Date.

    No fractional shares of Concentra's common stock were distributed. Instead, Select Medical's stockholders will receive cash in lieu of any fraction of a share of Concentra's common stock that they otherwise would have received.

    On November 19, 2024, Select Medical made available an information statement to its stockholders on the Record Date, which included details on the Distribution. The information statement is posted under the Investor Relations tab on Select Medical's website at www.selectmedical.com/investor-relations/.

    J.P. Morgan and Goldman Sachs acted as financial advisors to Select Medical in connection with the Distribution. Dechert LLP acted as legal advisor to Select Medical in connection with the Distribution.

    About Select Medical

    Select Medical is one of the largest operators of critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States based on number of facilities. Select Medical's reportable segments include the critical illness recovery hospital segment, the rehabilitation hospital segment, the outpatient rehabilitation segment, and the Concentra segment. As of September 30, 2024, Select Medical operated 106 critical illness recovery hospitals in 29 states, 34 rehabilitation hospitals in 13 states, 1,925 outpatient rehabilitation clinics in 39 states and the District of Columbia, and 549 occupational health centers in 41 states. At September 30, 2024, Select Medical had operations in 46 states and the District of Columbia. Information about Select Medical is available at www.selectmedical.com.

    This press release may contain forward-looking statements based on current management expectations. Numerous factors, including those related to market conditions and those detailed from time-to-time in Select Medical's filings with the Securities and Exchange Commission, may cause results to differ materially from those anticipated in the forward-looking statements. Many of the factors that will determine Select Medical's future results are beyond the ability of Select Medical to control or predict. These statements are subject to risks and uncertainties and, therefore, actual results may differ materially. Readers should not place undue reliance on forward-looking statements, which reflect management's views only as of the date hereof. Select Medical undertakes no obligation to revise or update any forward-looking statements, or to make any other forward-looking statements, whether as a result of new information, future events or otherwise.

    Investor inquiries:

    Joel T. Veit

    Senior Vice President and Treasurer

    717-972-1100

    [email protected]

    Cision View original content:https://www.prnewswire.com/news-releases/select-medical-holdings-corporation-completes-spin-off-of-concentra-302315858.html

    SOURCE Select Medical Holdings Corporation

    Get the next $CON alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Q&A

    New
    • What significant corporate action did Select Medical Holdings Corporation announce?

      Select Medical completed the distribution of 104,093,503 shares of common stock of Concentra, representing 81.7% of Concentra's outstanding shares, to its stockholders.

    • When was the distribution of Concentra's shares completed?

      The distribution took place on November 25, 2024, to stockholders on the record date of November 18, 2024.

    • How many shares of Concentra's stock were distributed to Select Medical's stockholders for each share they owned?

      Stockholders received 0.806971 shares of Concentra's common stock for each share of Select Medical's stock they held as of the record date.

    • What will happen to fractional shares of Concentra's common stock that stockholders would have otherwise received?

      Select Medical stockholders will receive cash in lieu of any fractional shares of Concentra, as no fractional shares were distributed.

    • Who were the financial and legal advisors for Select Medical in this distribution?

      J.P. Morgan and Goldman Sachs acted as financial advisors, while Dechert LLP served as legal counsel to Select Medical during the distribution process.

    Recent Analyst Ratings for
    $CON
    $SEM

    CompanyDatePrice TargetRatingAnalyst
    Select Medical Holdings Corporation
    $SEM
    10/8/2025$16.00 → $20.00Outperform
    RBC Capital Mkts
    Concentra Group Holdings Parent Inc.
    $CON
    9/18/2025$31.00Overweight
    Analyst
    Select Medical Holdings Corporation
    $SEM
    4/16/2025$25.00Outperform
    Mizuho
    Select Medical Holdings Corporation
    $SEM
    2/24/2025$23.00Hold → Buy
    The Benchmark Company
    Concentra Group Holdings Parent Inc.
    $CON
    12/16/2024$24.00Neutral → Buy
    BofA Securities
    Select Medical Holdings Corporation
    $SEM
    11/25/2024Buy → Hold
    The Benchmark Company
    Concentra Group Holdings Parent Inc.
    $CON
    10/7/2024$30.50 → $24.00Buy → Neutral
    BofA Securities
    Select Medical Holdings Corporation
    $SEM
    8/20/2024$42.00Buy
    BofA Securities
    More analyst ratings

    $CON
    $SEM
    SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13D/A filed by Concentra Group Holdings Parent Inc.

    SCHEDULE 13D/A - Concentra Group Holdings Parent, Inc. (0002014596) (Subject)

    11/26/25 4:15:20 PM ET
    $CON
    Medical Specialities
    Health Care

    Select Medical Holdings Corporation filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - SELECT MEDICAL HOLDINGS CORP (0001320414) (Filer)

    11/25/25 8:15:41 AM ET
    $SEM
    Hospital/Nursing Management
    Health Care

    SEC Form SCHEDULE 13D filed by Select Medical Holdings Corporation

    SCHEDULE 13D - SELECT MEDICAL HOLDINGS CORP (0001320414) (Subject)

    11/24/25 4:46:42 PM ET
    $SEM
    Hospital/Nursing Management
    Health Care

    $CON
    $SEM
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Khanuja Parvinderjit S. bought $315,420 worth of shares (21,000 units at $15.02), increasing direct ownership by 48% to 65,089 units (SEC Form 4)

    4 - SELECT MEDICAL HOLDINGS CORP (0001320414) (Issuer)

    5/6/25 6:21:53 PM ET
    $SEM
    Hospital/Nursing Management
    Health Care

    $CON
    $SEM
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    RBC Capital Mkts reiterated coverage on Select Medical with a new price target

    RBC Capital Mkts reiterated coverage of Select Medical with a rating of Outperform and set a new price target of $20.00 from $16.00 previously

    10/8/25 10:00:36 AM ET
    $SEM
    Hospital/Nursing Management
    Health Care

    Analyst resumed coverage on Concentra with a new price target

    Analyst resumed coverage of Concentra with a rating of Overweight and set a new price target of $31.00

    9/18/25 8:38:55 AM ET
    $CON
    Medical Specialities
    Health Care

    Mizuho initiated coverage on Select Medical with a new price target

    Mizuho initiated coverage of Select Medical with a rating of Outperform and set a new price target of $25.00

    4/16/25 9:09:30 AM ET
    $SEM
    Hospital/Nursing Management
    Health Care

    $CON
    $SEM
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Concentra Expands to Corona, California

    Concentra® (NYSE:CON), the nation's leader in occupational medicine, today announced the opening of a new medical center in Corona, California. The medical center, Concentra Corona, is conveniently located at 629 North Main Street, Unit C-3, Corona, California 92878. "We're excited to bring our medical services to Corona," said Kathy Le, MD, senior vice president of Concentra medical operations. "It's a great opportunity for us to expand access to care for employers and employees in the area." Concentra will provide work injury care, physical therapy, drug testing, DOT physical exams, pre-placement exams, and other employer-related health services from its new location in Corona. Telemedi

    12/8/25 8:00:00 AM ET
    $CON
    Medical Specialities
    Health Care

    Select Medical Holdings Corporation Acknowledges Executive Chairman's Take-Private Proposal

    MECHANICSBURG, Pa., Nov. 24, 2025 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical," "we," "us," or "our") (NYSE:SEM) has received a non-binding indication of interest from Robert A. Ortenzio, Executive Chairman, Co-Founder and Director of Select Medical, to acquire all of the outstanding shares of Select Medical for cash consideration of $16.00 to $16.20 per share of our common stock (the "Proposal"). Mr. Ortenzio publicly announced the Proposal on November 24, 2025 in a Schedule 13D filing with the U.S. Securities and Exchange Commission. The disinterested members of the Board of Directors of Select Medical are carefully reviewing and evaluating the Proposal in consult

    11/24/25 8:30:00 PM ET
    $SEM
    Hospital/Nursing Management
    Health Care

    Concentra Appoints Jason Cooper as Chief Data, Analytics, and Artificial Intelligence Officer

    Concentra®, (NYSE:CON) the nation's largest provider of occupational health services, today announced the appointment of Jason Cooper as Chief Data, Analytics, and Artificial Intelligence Officer. In this role, he will ensure Concentra's data strategy and governance, technology enablement, and insight generation are aligned with enterprise growth priorities. "Selecting Jason as our Chief Data, Analytics, and Artificial Intelligence Officer represents the natural progression of Concentra's established foundation in data, technology, and innovation," said Keith Newton, Chief Executive Officer of Concentra. "His expertise and extensive experience will enable us to continue to operationalize

    11/10/25 4:30:00 PM ET
    $CON
    Medical Specialities
    Health Care

    $CON
    $SEM
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Officer Ryan Timothy F. covered exercise/tax liability with 5,903 shares, decreasing direct ownership by 5% to 114,097 units (SEC Form 4)

    4 - Concentra Group Holdings Parent, Inc. (0002014596) (Issuer)

    12/1/25 4:23:27 PM ET
    $CON
    Medical Specialities
    Health Care

    Officer Rhine Michael D. covered exercise/tax liability with 3,935 shares, decreasing direct ownership by 5% to 76,163 units (SEC Form 4)

    4 - Concentra Group Holdings Parent, Inc. (0002014596) (Issuer)

    12/1/25 4:22:41 PM ET
    $CON
    Medical Specialities
    Health Care

    Officer Nelson Su Zan covered exercise/tax liability with 5,903 shares, decreasing direct ownership by 5% to 114,097 units (SEC Form 4)

    4 - Concentra Group Holdings Parent, Inc. (0002014596) (Issuer)

    12/1/25 4:20:03 PM ET
    $CON
    Medical Specialities
    Health Care

    $CON
    $SEM
    Financials

    Live finance-specific insights

    View All

    Concentra® to Announce Third Quarter 2025 Results on Thursday, November 6, 2025

    Concentra® Group Holdings Parent, Inc. ("Concentra") (NYSE:CON) will release the financial results for its third quarter ended September 30, 2025, on Thursday, November 6, 2025, after the market closes. Concentra will host a conference call regarding its financial results on Friday, November 7, 2025, at 9 a.m. Eastern Time. The conference call will be a live webcast and can be accessed via this Earnings Call Webcast Link or via Concentra's investor relations website. A replay of the webcast will be available shortly after the call at the same locations. Participants may join the audio-only version of the webcast or participate in the question-and-answer session by calling: Toll Free:

    10/6/25 4:30:00 PM ET
    $CON
    Medical Specialities
    Health Care

    Select Medical Holdings Corporation to Announce Third Quarter 2025 Results on Thursday, October 30, 2025

    MECHANICSBURG, Pa., Oct. 2, 2025 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical") (NYSE:SEM), will release the financial results for its third quarter ended September 30, 2025 on Thursday, October 30, 2025 after the market closes. Select Medical will host a conference call regarding its third quarter results, as well as its business outlook, on Friday, October 31, 2025, at 9:00am ET. The conference call will be a live webcast and can be accessed at via this Earnings Call Webcast Link or via link at Select Medical Holdings Corporation's website at www.selectmedicalholdings.com. A replay of the webcast will be available shortly after the call through the same link. For l

    10/2/25 4:15:00 PM ET
    $SEM
    Hospital/Nursing Management
    Health Care

    Concentra Group Holdings Parent, Inc. Announces Results For Its Second Quarter Ended June 30, 2025, Cash Dividend, and Raised FY 2025 Guidance

    Concentra Group Holdings Parent, Inc. ("Concentra," the "Company," "we," "us," or "our") (NYSE:CON), the nation's largest provider of occupational health services, today announced results for its second quarter ended June 30, 2025, the declaration of a cash dividend, and raised guidance for FY 2025. "Concentra delivered strong results in the second quarter, building on our solid start to 2025," said Keith Newton, Chief Executive Officer of Concentra. "Our results reflected strength across several key measures, including growth in patient visits, rate, revenue, and Adjusted EBITDA. We are well-positioned for continued momentum driven by the disciplined execution of our strategy by our outs

    8/7/25 4:30:00 PM ET
    $CON
    Medical Specialities
    Health Care

    $CON
    $SEM
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Concentra Group Holdings Parent Inc.

    SC 13G - Concentra Group Holdings Parent, Inc. (0002014596) (Subject)

    12/9/24 6:02:26 AM ET
    $CON
    Medical Specialities
    Health Care

    SEC Form SC 13G filed by Concentra Group Holdings Parent Inc.

    SC 13G - Concentra Group Holdings Parent, Inc. (0002014596) (Subject)

    12/6/24 4:32:57 PM ET
    $CON
    Medical Specialities
    Health Care

    SEC Form SC 13D filed by Concentra Group Holdings Parent Inc.

    SC 13D - Concentra Group Holdings Parent, Inc. (0002014596) (Subject)

    12/3/24 4:21:17 PM ET
    $CON
    Medical Specialities
    Health Care

    $CON
    $SEM
    Leadership Updates

    Live Leadership Updates

    View All

    Concentra Appoints Jason Cooper as Chief Data, Analytics, and Artificial Intelligence Officer

    Concentra®, (NYSE:CON) the nation's largest provider of occupational health services, today announced the appointment of Jason Cooper as Chief Data, Analytics, and Artificial Intelligence Officer. In this role, he will ensure Concentra's data strategy and governance, technology enablement, and insight generation are aligned with enterprise growth priorities. "Selecting Jason as our Chief Data, Analytics, and Artificial Intelligence Officer represents the natural progression of Concentra's established foundation in data, technology, and innovation," said Keith Newton, Chief Executive Officer of Concentra. "His expertise and extensive experience will enable us to continue to operationalize

    11/10/25 4:30:00 PM ET
    $CON
    Medical Specialities
    Health Care

    SELECT MEDICAL HOLDINGS CORPORATION APPOINTS THOMAS P. MULLIN AS CHIEF EXECUTIVE OFFICER AND ANNOUNCES OTHER CHANGES INVOLVING LONG-TENURED LEADERS

    MECHANICSBURG, Pa., Sept. 2, 2025 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical") (NYSE:SEM) today announced the appointment of Thomas P. Mullin as its chief executive officer.  David S. Chernow, who has held the position since 2014, has been appointed vice chairman of the board.  John A. Saich, who most recently held the position of co-president, will serve as the company's sole president.  John F. Duggan has been appointed executive vice president, general counsel and secretary.  The appointments are effective immediately. Mr. Mullin joined Select Medical in 2008, most recently serving as co-president overseeing 140 critical illness recovery and inpatient rehabilita

    9/2/25 4:10:00 PM ET
    $SEM
    Hospital/Nursing Management
    Health Care

    Concentra Announces the Appointment Of Vipin Gopal and Brigid Bonner To Its Board Of Directors

    Concentra® Group Holdings Parent, Inc. ("Concentra") (NYSE:CON), today announced the appointment of Vipin Gopal and Brigid Bonner to the Concentra Board of Directors, marking a strategic milestone for the occupational health services company. "We are pleased to welcome Vipin Gopal and Brigid Bonner to the Concentra Board," said Bob Ortenzio, Concentra's board chair. "As Concentra navigates growth and the opportunity to increase shareholder value, expanding the Board with two prominent health care leaders with data, technology, and business transformation expertise will prove to be a mobilizing force for the company." Vipin Gopal, PhD, brings over 25 years of experience successfully lead

    6/26/25 4:30:00 PM ET
    $CON
    Medical Specialities
    Health Care